Article Details
Retrieved on: 2025-02-10 12:35:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Invivyd, which focuses on monoclonal antibodies for viral diseases, reported positive data from its ongoing Phase 1/2 trial of VYD2311, a ...
Article found on: newsable.asianetnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here